@ARTICLE{
author={Ciardiello F,Feng Z,Smith NR,Andric Zoran G,Shell S,Yablonovitch A,Guezel G,Scheuenpflug J},
year={2022},
title={Clinical potential of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response to firstline (1L) chemoimmunotherapy in advanced squamous non-small cell lung cancer (sqNSCLC)},
journal={ANNALS OF ONCOLOGY},
volume={33},
number={7},
pages={S1050-S1051},
document_type={Meeting Abstract},
}